BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 15384170)

  • 1. Selection of pediatric candidates under the PELD system.
    McDiarmid SV; Merion RM; Dykstra DM; Harper AM
    Liver Transpl; 2004 Oct; 10(10 Suppl 2):S23-30. PubMed ID: 15384170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overview of the MELD/PELD system of liver allocation indications for liver transplantation in the MELD era: evidence-based patient selection.
    Freeman RB
    Liver Transpl; 2004 Oct; 10(10 Suppl 2):S2-3. PubMed ID: 15382218
    [No Abstract]   [Full Text] [Related]  

  • 3. National and regional analysis of exceptions to the Pediatric End-Stage Liver Disease scoring system (2003-2004).
    Shneider BL; Suchy FJ; Emre S
    Liver Transpl; 2006 Jan; 12(1):40-5. PubMed ID: 16382460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selection of candidates with HCC for transplantation in the MELD era.
    Sala M; Varela M; Bruix J
    Liver Transpl; 2004 Oct; 10(10 Suppl 2):S4-9. PubMed ID: 15382217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Organ allocation for liver-intestine candidates.
    Horslen S
    Liver Transpl; 2004 Oct; 10(10 Suppl 2):S86-9. PubMed ID: 15382223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. When is a patient too well and when is a patient too sick for a liver transplant?
    Merion RM
    Liver Transpl; 2004 Oct; 10(10 Suppl 2):S69-73. PubMed ID: 15382215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of a continuous disease severity score to the OPTN liver waiting list.
    Edwards EB; Harper AM
    Clin Transpl; 2001; ():19-24. PubMed ID: 12211782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pediatric end-stage liver disease (PELD) model as a predictor of survival benefit and posttransplant survival in pediatric liver transplant recipients.
    Barshes NR; Lee TC; Udell IW; O'mahoney CA; Karpen SJ; Carter BA; Goss JA
    Liver Transpl; 2006 Mar; 12(3):475-80. PubMed ID: 16498644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does MELD work for relisted candidates?
    Edwards E; Harper A
    Liver Transpl; 2004 Oct; 10(10 Suppl 2):S10-6. PubMed ID: 15382287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of PELD on OPTN liver allocation: preliminary results.
    Davies DB
    Clin Transpl; 2003; ():13-20. PubMed ID: 15387095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Model for end-stage liver disease: impact of the new deceased donor liver allocation policy in São Paulo, Brazil.
    Monteiro F; Coria SA; Boni R; Pereira LA
    Transplant Proc; 2009; 41(1):226-8. PubMed ID: 19249520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ABO blood group-related waiting list disparities in liver transplant candidates: effect of the MELD adoption.
    Barone M; Avolio AW; Di Leo A; Burra P; Francavilla A
    Transplantation; 2008 Mar; 85(6):844-9. PubMed ID: 18360266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of MELD on OPTN liver allocation: preliminary results.
    Edwards EB; Harper AM
    Clin Transpl; 2002; ():21-8. PubMed ID: 12971434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The value of MELD in the allocation of priority for liver transplantation candidates].
    Colmenero J; Castro-Narro G; Navasa M
    Gastroenterol Hepatol; 2010 Apr; 33(4):330-6. PubMed ID: 19631411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modified pediatric end-stage liver disease scoring system and pediatric liver transplantation in Brazil.
    Neto JS; Carone E; Pugliese RP; Fonseca EA; Porta G; Miura I; Danesi VB; Guimaraes TC; Godoy AL; Porta A; Vincenzi R; Carnevale F; Kondo M; Chapchap P
    Liver Transpl; 2010 Apr; 16(4):426-30. PubMed ID: 20213836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Consequences of the implementation of the Model for End-stage Liver Disease system for liver allocation in Brazil.
    Pestana RC; Baracat EI; Massarollo PC; Pereira LA; Szutan LA
    Transplant Proc; 2013; 45(6):2111-4. PubMed ID: 23747144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Child-Turcotte-Pugh and pediatric end-stage liver disease scoring systems to predict morbidity and mortality of children awaiting liver transplantation.
    Dehghani SM; Gholami S; Bahador A; Haghighat M; Imanieh MH; Nikeghbalian S; Salahi H; Davari HR; Mehrabani D; Malek-Hosseini SA
    Transplant Proc; 2007 Dec; 39(10):3175-7. PubMed ID: 18089346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Model for End-Stage Liver Disease (MELD) score system to evaluate patients with viral hepatitis on the waiting list: better than the Child-Turcotte-Pugh (CTP) system?
    Cuomo O; Perrella A; Arenga G
    Transplant Proc; 2008; 40(6):1906-9. PubMed ID: 18675085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of the MELD score on waiting time and disease severity in liver transplantation in United States veterans.
    Ahmad J; Downey KK; Akoad M; Cacciarelli TV
    Liver Transpl; 2007 Nov; 13(11):1564-9. PubMed ID: 17969210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variation of the MELD score as a predictor of death on the waiting list for liver transplantation.
    Gheorghe L; Iacob S; Iacob R; Gheorghe C; Popescu I
    J Gastrointestin Liver Dis; 2007 Sep; 16(3):267-72. PubMed ID: 17925920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.